TAC-PF
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAC-PF, covering 2010-03-24 to 2010-03-24. Get the full timeline:
Most recent: Clinical Trial Update: TAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular Degeneration [Phase 2]